CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Grant or award Director acquired 1,370 shares (grant or award)
- 4 Grant or award Director acquired 1,370 shares (grant or award)
- 4 Grant or award Director acquired 1,370 shares (grant or award)
- 4 Grant or award Director acquired 1,370 shares (grant or award)
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-4 Deal Registration Statement - Business Combination
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 84 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes Chief Executive Officer gave up 2,746 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 110 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 977 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 117 shares (to pay taxes)
Page 19 of 137 · 2,721 filings